Patent details

EP1551409 Title: USE OF THE QUINAZOLINE DERIVATIVE ZD6474 COMBINED WITH GEMCITABINE AND OPTIONALLY IONISING RADIATION IN THE TREATMENT OF CANCER

Basic Information

Publication number:
EP1551409
PCT Application Number:
PCT/GB/2003/004334
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP037510328
PCT Publication Number:
WO/2004/032937
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
USE OF THE QUINAZOLINE DERIVATIVE ZD6474 COMBINED WITH GEMCITABINE AND OPTIONALLY IONISING RADIATION IN THE TREATMENT OF CANCER
French Title of Invention:
UTILISATION DU DERIVE DE LA QUINAZOLINE ZD6474 COMBINE A LA GEMCITABINE ET EVENTUELLEMENT AU RAYONNEMENT IONISANT DANS LE TRAITEMENT DU CANCER
German Title of Invention:
VERWENDUNG VON DEM QUINAZOLIN DERIVAT ZD6474 KOMBINIERT MIT GEMCITABIN UND GEGEBENENFALLS IONISIERENDER STRAHLUNG FÜR DIE BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
06/10/2003
Grant date:
21/03/2007
EP Publication Date:
21/03/2007
PCT Publication Date:
22/04/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
13/07/2005
EP B1 Publication Date:
21/03/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
06/10/2013
Expiration date:
06/10/2023
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/10/2003
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

Name:
VAN MALDEREN MICHEL
From:
12/04/2007
Address:
ROUTE D'ARLON 261, 8002, STRASSSEN, Luxembourg (LU)
To:

Inventor

Name:
BARGE Alan, AstraZeneca R & D Alderley
Address:
United Kingdom (GB)

Priority

Priority Number:
0223380
Priority Date:
09/10/2002
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
A61K 31/517;
Filing date Document type Number of pages